Delivery Order SPE2DB20D3111-SPE2DB25FA8TF
- Not listed
- The Defense Logistics Agency awarded a $57,155.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on August 11, 2025, with completion targeted for August 12, 2025. This competitively awarded, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $2,284.27 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination respiratory medication used to treat chronic obstructive...
- The Defense Logistics Agency awarded a delivery order valued at $16,076.36 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $3,536.93 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a non-set-aside competitive award with an ultimate completion date of July 15, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is...
- The Defense Logistics Agency awarded a delivery order valued at $11,129.60 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed price delivery order was issued without a set-aside designation and reflects a competitively awarded transaction. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Trelegy Ellipta is a...
- The Defense Logistics Agency awarded a delivery order valued at $8,989.71 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $4,955.40 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count), with an ultimate completion date of August 4, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child award issued under a larger indefinite delivery contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $41,772.77 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count packages), with a completion date of September 2, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.99 million...
- The Defense Logistics Agency awarded a delivery order valued at $12,469.97 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count supply) on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a prescription combination medication used for the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,832.12 on August 28, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination inhaler used for maintenance...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA8TFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,059.98 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count supply). This firm fixed price, non-competitive delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination pharmaceutical product used in respiratory disease management, reflecting the Defense Logistics Agency's ongoing procurement of critical medical supplies for military and veteran healthcare systems. This delivery order represents a child contract under AmerisourceBergen's significantly larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains an extensive portfolio of competitively awarded federal contracts with the Defense Logistics Agency covering diverse therapeutic domains including specialty medications, vaccines, and medical devices for Defense Health Agency and U.S. Coast Guard customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/30/25 |